<DOC>
	<DOCNO>NCT00581100</DOCNO>
	<brief_summary>The purpose study evaluate Etanercept administer high initial dose provide great improvement nail skin psoriasis symptom regimen low initial dose .</brief_summary>
	<brief_title>Effects Etanercept Nail Psoriasis Plaque Psoriasis</brief_title>
	<detailed_description>This study assess effect 2 Etanercept regimen fingernail psoriasis 24 week among patient skin fingernail symptom previously fail least one therapy nail psoriasis . The endpoint 24 week choose allow sufficient time normal nail growth .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>18 year age old Active , stable plaque psoriasis define follow criterion : Body surface area ( BSA ) ≥ 10 % screen baseline Or , PASI &gt; 10 screen baseline Or , PGA Psoriasis status moderate worse ( moderate , mark , severe ) screen baseline Or , DLQI &gt; 10 baseline Active fingernail psoriasis define target fingernail NAPSI ≥ 2 overall NAPSI &gt; 14 Target nail define nail high nail score ( matrix+bed score ) baseline . Should one fingernail score , target fingernail choose investigator . Failure least one systemic psoriasis therapy nail psoriasis Eligible receive biologic therapy psoriasis accordance local guideline Evidence Skin condition psoriasis Psoralen plus ultraviolet radiation ( PUVA ) , cyclosporine , alefacept , methotrexate , acitretin , systemic antipsoriasis therapy within 28 day study drug initiation Prior exposure TNFinhibitor . Prior exposure efalizumab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Nail Psoriasis</keyword>
	<keyword>Plaque Psoriasis</keyword>
</DOC>